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1. Introduction 
Firefly luciferase (Fluc) catalyzes a bioluminescent reaction using the substrates ATP and 
beetle luciferin in the presence of molecular oxygen (Fig. 1A). Because of its use of ATP and 
the simplicity of the single-enzyme system, firefly luciferase is widely used in numerous 
applications, notably those involving detection of living organisms, gene expression or 
amplification in both in vivo and in vitro systems.  
 
A 
 
B C 
Fig. 1. Bioluminescent reaction of Fluc (A) and chemical structures of luciferin (LH2) (B) and 
aminoluciferin (ALH2) (C) eliciting intense bioluminescence. 
Fluc has found intensive application in small animal in vivo bioluminescence imaging (BLI) 
in which the activity or state of labelled proteins, cells, tissues and organs may be localised 
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and quantified sensitively and non-invasively. Different models and procedures for BLI are 
well described (Kung, 2005; Zinn et al., 2008). For example, BLI is routinely applied to 
serially detect the burden of xenografted tumours in mice. Using more complex techniques, 
such as Fluc re-complementation, protein interactions such as chemokine receptor 
dimerisation (Luker et al., 2008) have been imaged in small animals.  
Recently, BLI has also been adapted to the detection of small molecules in vivo (Van de 
Bittner et al., 2010). D-LH2 is typically given intravenously or intraperitoneally to mice and 
has a broad biodistribution profile (Berger et al., 2010). Cellular levels of Mg and ATP are 
sufficient to drive the reaction, though kinetics depends on substrate diffusion. Light 
emitted from labelled cells is detected using imagers which consist of CCD cameras in a 
dark box. This gives invaluable insight into the effects of experiments in the context of living 
organisms in real time.  
The advantages of BLI over comparative techniques such as positron emission tomography 
(PET) include its simplicity, low cost, non-requirement for radiation and versatility. The 
other main optical imaging technique, fluorescence imaging (FLI), in which fluorescent 
small molecules or proteins are imaged in small animals, has lower signal to noise ratio than 
BLI due to the background signal in FLI from autofluorescence, quenching of signal due to 
endogenous tissue chromophores and also the requirement, and dependence on 
penetration, of an excitation light. Thus, BLI is approximately three orders of magnitude 
more sensitive than FLI and has a very large dynamic range (Wood, 1998).  
All optical imaging techniques suffer from low resolution and from wavelength dependence 
of imaging due to photon scatter and signal attenuation by endogenous absorbing 
compounds. For example haemoglobin absorbs strongly below 590 nm. Therefore it is the 
red part of the spectra that is detected most efficiently (Caysa et al., 2009).  
Wild-type (WT) luciferase is highly thermolabile, inactivating and bathochromic shifting at 
even room temperature, and is sensitive to buffer conditions such as pH (Law et al., 2006). 
The recombinant WT luciferase retains between 30 and 45% of activity at pH 7.0 relative to 
that at the optimal pH of 7.8 – 8.0, depending on whether flash heights or integrated light 
were measured (Law et al., 2006). While many in vitro applications, such as those used to 
detect DNA amplification (Gandelman et al., 2010) or ATP-assays (Strehler, 1968), take place 
at alkaline pH values of 8.0 or higher, in vivo applications such as medical or whole cell 
imaging must take place at neutral pH of 6.9 – 7.2, dependent on the exact cell type. At 37ºC, 
WT Fluc shows a bathochromic shift and thus emits predominantly red light. Though light 
of red and longer wavelength does penetrate tissues more readily, red-shift luciferase 
bioluminescence is usually accompanied by a significant reduction in quantum yield and is 
therefore as such undesirable (Seliger and McElroy, 1959; Seliger and McElroy, 1960) as 
fluctuating levels of luciferase activity make quantitative studies problematic.  Furthermore, 
for multispectral purposes (Mezzanotte et al., 2011), any shift is undesirable. Therefore 
thermostable enzymes of different colours, which resist bathochromic shift are preferable.  
The ideal Fluc would be highly thermostable, resist bathochromic shift, bright, have 
favourable kinetics (such as high substrate affinity) and have increased pH-tolerance. To 
address the issues of thermostability and bathochromic shift a number of recombinant 
mutant luciferases with increased thermal stability, giving brighter and more stable signals 
at elevated temperatures and resistant to bathochromic shift have been developed using 
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protein engineering (Hall et al., 1999; Tisi et al., 2002; Branchini et al., 2009). Enhanced 
thermostability greatly improves the brightness achievable in vivo, and such enzymes are 
just recently finding application in animals (Law et al., 2006; Baggett et al., 2004; Mezzanotte 
et al., 2011; Michelini et al., 2008). A combination of higher thermal stability with increased 
pH-tolerance of Fluc is a very much desired and favourable feature for in vivo imaging 
which is likely to be useful in other applications (Foucault et al., 2010). 
Thermostability can be greatly improved by one amino acid change of FLuc and it has been 
observed that both changes in the enzyme core and on the protein surface can alter stability 
(Tisi et al., 2002b). The substitutions A217I, L or V, identified by random mutagenesis 
increase the thermo- and pH-stability of Luciola cruciata and L. lateralis Flucs, and the 
equivalent substitution in Photinus pyralis (Ppy) Luc (A215L) also increases thermostability 
(Kajiyama and Nakano, 1993; Squirrell et al., 1998). By random mutagenesis of Ppy Luc, and 
N-terminal surface loop-based substitutions, E354K or E354R have been identified to 
increase thermostability (White et al., 1996). Combination of E354 with mutation D357 
produced thermostable double mutants, of which E354I/ D357Y (x2 Fluc; Table 1) and 
E354R/ D357F were shown to be more stable than D357Y or E354K alone (Willey et al., 
2001).  
Cumulative addition of such mutations further enhances thermostability. A typical example 
is a mutant containing T214C, I232A, F295L and E354K, named x4 Luc (Table 1) (Tisi et al., 
2002b). Non-conserved surface-exposed hydrophobic residues previously mutated to Ala 
(Tisi et al., 2001; Prebble et al., 2001) have also been substituted for polar ones (F14R, L35Q, 
V182K, I232K and F465R) to produce a mutant, named x5 Luc, displaying additively 
improved thermostability, solvent stability and pH-tolerance in terms of activity and 
resistance to red-shift; while retaining the same specific activity relative to WT luciferase 
(Law et al., 2002; Law et al., 2006). The most thermostable mutant luciferase, Ultra-GloTM 
(UG) was created from Photuris pennsylvanica luciferase, and is commercially available for a 
number of assays (Hall et al., 1999; Woodroofe et al., 2008).  
Majority of studies on improving thermostability, pH-tolerance and brightness of Fluc have 
been carried out using LH2 until now. Emerging applications of luciferases in in vivo 
imaging of protease activity (Dragulescu-Andrasi et al., 2009) require a different substrate - 
ALH2, one of the very few LH2 analogues with which firefly luciferase also produces 
bioluminescence of relatively high intensity (White et al., 1966). The substitution of the 6’-
group extends the range of groups that can be conjugated to luciferin, for example to amino 
acids (Shinde et al., 2006), peptides (Monsees et al., 1995) and linear or bulky N-alkyl groups 
(Woodroofe et al., 2008). Peptide-conjugated pro-luciferins allow the bioluminescent 
measurement of protease activity and in such applications ALH2 (Monsees et al., 1995) 
therefore the properties of different firefly luciferases and their mutants with ALH2 may 
impact on the choice of enzymes applied. 
The limited data on Ppy Fluc bioluminescence with ALH2 as a substrate show that these 
properties are very different from those of LH2. The bioluminescence colour with ALH2 has 
long been reported as pH-independent orange-red (max 605nm) (White et al., 1966), Km for 
ALH2 is approximately 26-times lower and Vmax is 10 times lower than that of LH2 (Shinde 
et al., 2006). There has been no further analysis of either red-shifted excited state emitter with 
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ALH2 or its higher catalytic efficiency. From other studies it is known that there are 
luciferase isoforms from Pyrophorus plagiopthalamus that emit green light (PpldGr: 550 nm at 
pH 7.6) and yellow light (PplvY: 577 nm at pH 7.6) with ALH2. This indicates that red 
emission is not an intrinsic property of ALH2, but merely a consequence of enzymatic 
interactions and conformation of the active site (White et al., 1966; Nakatsu et al., 2006; 
Branchini et al., 2001; Sandalova and Ugarova, 1999). Thus, it should be possible to engineer 
luciferase mutants with advantageous properties with ALH2, such as altered emission 
colour, higher activity and/or kinetics beneficial for in vivo imaging of protease activity.  
In this paper we report on the construction and characterisation of a further improved x12 
mutant based on the x5 mutant and seven additional mutations. Each of these mutations has 
previously been shown to confer slower rates of thermal inactivation (White et al., 1996; 
Squirrell et al., 1999; Tisi et al., 2002).  We compared the performance of x12 mutant with the 
WT Ppy and UG luciferases and demonstrated its pH tolerance and increased 
thermostability. A reversion of one of the mutations in the x12 resulted in a simplified 
mutant, termed x11 Fluc. Herein, we present properties of this mutant, which is highly 
thermostable, pH-tolerant, has high activity and catalytic efficiency with both LH2 and 
ALH2, and presents a great potential for in vivo applications with both substrates.  
2. Materials and methods 
2.1 Materials 
D-LH2 potassium salt was obtained from Europa Bioproducts and D-ALH2 from Marker 
Gene Technologies Inc. (Eugene, OR, USA). x2 Fluc was donated by Dr. Peter White (Dstl, 
Porton Down, Salisbury, UK) [White et al., 2002; Willey et al., 2001]. Ultra-GloTM luciferase 
(UG) was purchased from Promega and all other chemicals were purchased from Melford 
Laboratories Ltd. or Sigma-Aldrich unless otherwise specified.  
2.2 Construction of the x12 Fluc mutant and revertants 
Seven mutations were introduced sequentially onto the 5 luciferase gene in pET16b-luc5 
(Law et al., 2006) using the QuickChangeTM Site Directed Mutagenesis (SDM) kit 
(Stratagene) according to the manufacturer’s protocol. The primers used for the seven 
rounds of SDM are as follow:  
5’-GCAGTTGCGCCCGTGAACGAC-3’ and 5’-GTCGTTCACGGGCGCAACTGC-3’ for 
A105V; 5’-CCCTATTTTCATTCCTGGCCAAAAGCACTC-3’ and 5’-
GAGTGCTTTTGGCCAGGAATGAAAATAGGG-3’ for F295L; 5’-
GGCTACATACTGGAGACATAGC-3’ and 5’-GCTATGTCTCCAGTATGTAGCC-3’ for 
S420T; 
5’-CAAATCAAACCGGGTACTGCGATTTTAAG-3’ and 5’-
CTTAAAATCGCAGTACCCGGTTTGATTTG-3’ for D234G; 5’-
CCGCATAGATGTGCCTGCGTCAGATTC-3’ and 5’-
GAATCTGACGCAGGCACATCTATGCGG-3’ for T214C; 
5’-CACCCCGCGGGGATTATAAACCGGG-3’ and 5’-
CCCGGTTTATAATCCCCGCGGGGTG-3’ (AvaI) for E354R and D357Y 
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Boldface type represents the mutated codon, underlined letters represent modified 
endonuclease site used to facilitate screening, and the endonuclease used for screening is 
shown in parentheses. E. coli BL21 (pLysS) (Edge Biosystems, Gaithersburg, MD, USA or 
XL2-Blue ultracompetent cells (Stratagene) were used as cloning hosts for the generation 
and selection of mutants from site-directed mutagenesis. Expression from colonies was 
induced by adsorbing colonies onto HybondTM-N nitrocellulose membranes (Amersham 
Biosciences Corp., Piscataway, NJ, USA) and transferring membranes onto fresh Luria 
Bertani (LB) agar plates containing 100 g/ml carbenicillin and 1 mM IPTG and incubating 
for 3 hours at room temperature (RT). Bioluminescence was initiated by spraying 
membranes with 1 mM LH2 or 500M ALH2 in 0.1 M citrate buffer (pH 5) and colony 
screening was carried out by photographing emitted light with Nikon D70S camera (Nikon 
Corp., Tokyo, Japan). After seven rounds of SDM, mutations introduced were confirmed by 
sequencing of the entire luciferase gene using a facility provided by the Department of 
Genetics, University of Cambridge.  
2.3 Expression and purification of 12 Fluc and revertants 
His10-tagged WT recombinant luciferase (WT) and mutants were expressed and purified 
according to the optimised protocol described in (Law et al., 2006). Total protein 
concentrations were estimated by the method of Bradford (Bradford, 1976), using the 
Coomassie Blue protein assay reagent kit from Pierce according to the manufacturer’s 
protocol, with BSA as the standard. 
2.4 Luciferase activity assays, kinetic analysis, pH dependence of activity, thermal 
inactivation and bioluminescence spectra 
Luciferase mutants were diluted from purified stock solutions into pre-chilled 0.1 M Tris/ 
acetate; pH 7.8, 2 mM EDTA and 10 mM MgSO4 (TEM) containing 2 mM DTT to obtain the 
required concentration, unless specified otherwise. Refer to caption accompanying each 
table or figure for method details. Bioluminescence spectra were captured using a Varian 
fluorometer (Palo Alto, Ca, USA). For measurements at differing pH values, TEM buffer at 
different pH values was used to dilute substrates and enzymes. Data were corrected for 
variant PMT sensitivity as previously described (Law et al., 2006).  
2.5 Mammalian cell culture, retrovirus production and transduction of cells  
The genes encoding WT Fluc and x11 Fluc from pET16b constructs were cloned into 
mammalian retroviral expression vector SFG fused to Myc tags. These constructs were triple 
transfected into 293T cells, cultured in IMDM (Lonza, Basel, Switzerland) with 10% fetal calf 
serum (FCS) (Hyclone Labs Inc., Logan, UT, USA) and 1 % glutamax (Invitrogen Corp., 
Groningen, The Netherlands), along with plasmids encoding retroviral envelope and gagpol 
genes to produce retrovirus, which was used to transduce Raji cells. Transduced cells were 
sorted by flow cytometry using a Moflo-XDP instrument (Beckman Coulter, CA, USA) by 
anti-myc.FITC (Santa Cruz Biotechnology Inc., CA, USA) staining of the same mean 
fluorescence intensity and were cultured in RPMI 1640 (Lonza, Basel, Switzerland) with 10% 
FCS and 1 % glutamax in 5% CO2. 
www.intechopen.com
 
Bioluminescence – Recent Advances in Oceanic Measurements and Laboratory Applications 
 
124 
2.6 In vivo imaging 
Three month old Beta2m-mice were tail vein injected with 1 x 106 Raji cells expressing WT or 
x11 Fluc. These were imaged using 30-60 s exposures in an IVIS 200 imager (Caliper, NJ, 
USA) at days 3 and 10 after anaesthesia with isofluorane and 15 min after intra-peritoneal 
(i.p.) injection of 200 l of sterile D-luciferin (Regis Technologies, IL, USA).  
3. Results and discussion 
3.1 Construction, expression, purification and thermal inactivation of 12 Fluc and 
subset mutants 
Seven additional mutations, previously shown to confer slower rates of thermal inactivation 
of Fluc, were sequentially added onto the 5 Fluc by SDM to create x12 Fluc, which was 
expressed in BL21(DE3)pLysS and purified to > 90 % homogeneity as previously described 
(Law et al., 2006;  White et al., 1996; Tisi et al., 2002; Squirrell et al., 1999).  
 
Mutation 
Mutants 
Location 
x12 x11 x5 x4 x2 
F14R + + +   Surface 
L35Q + + +   Internal 
A105V + +    Surface 
V182K + + +   Surface 
T214A    +  Internal 
T214C + +    Internal 
I232A    +  Surface 
I232K + + +   Surface 
D234G + +    Surface 
F295L +   +  Internal 
E354R + +   + Surface 
E354K    +  Surface 
D357Y + +   + Surface 
S420T + +    Surface 
F465R + + +   Surface 
Table 1. Mutations and their positions in thermostable Fluc mutants 
The loss of activity of 12 Fluc was measured at 55C in two buffers, one of which allows 
direct comparison with the previously described 5 Fluc (Fig. 2A – buffer A) and the other, 
mimicking conditions used in BART (bioluminescent assay for monitoring nucleic acid 
amplification in real-time) (Fig. 2A – buffer B) (Tisi et al., 2002) . 12 Fluc retained 80% of 
starting total activity after 30 min of treatment at 55C, whereas 5 Fluc had < 1% activity 
remaining after 5 min at the same temperature (results not shown). When compared to 
previous thermostable Fluc mutants (Table 1) containing subsets of x12 Fluc mutations, x12 
Fluc was the most resistant to thermal inactivation at 40ºC (85-90% of initial activity after 
1hr) (Fig. 2B), followed by x4 and x2 Fluc (both 75-80% after 1hr) and then x5 Fluc (20% after 
1hr), which are all more stable than WT Fluc (fully inactivated within 10 min). 
www.intechopen.com
Development of a pH-Tolerant Thermostable  
Photinus pyralis Luciferase for Brighter In Vivo Imaging 
 
125 
0
0.2
0.4
0.6
0.8
1
1.2
0 5 10 15 20 25 30
Time (min
Buffer A
Buffer B
 
A B 
Thermal inactivation of x12 Fluc was determined at 55C in two different conditions, namely 200 nM of 
12 Fluc in Buffer A (50 mM phosphate buffer, pH 7.8, 10% glycerol (v/v), 2 mM DTT) and 86 nM of 
12 enzyme in Buffer B (20 mM Tris.Cl, pH 8.8, 10 mM KCl, 10 mM (NH4)2SO4, 0.1% Triton X-100 (v/v), 
5% trehalose (w/v), 0.5% BSA (w/v), 0.4 mg/ml PVP, 10 mM DTT). 30 l aliquots of enzyme in the 
respective condition were incubated in water bath at 55C for varying lengths of time up to 30 min. 
Enzyme activity was assayed by the injection of 100 l of TEM, pH 7.8, 1 mM ATP, 200 M LH2 into 
wells containing 5 l of enzyme and the measurement of flash height. PMT voltages used were 760 mV 
and 1000 mV for experiment in Buffer A and B respectively. Results shown are mean values  S.E.M. for 
triplicate measurements (A). Flash-based activity with LH2 was compared in aliquots of 0.5 M enzyme 
incubated at set temperatures over time. Samples equilibrated to room temperature before dispensing 
260 l 70 M LH2 and 1 mM ATP solution in TEM buffer (pH 7.8) into 40 l luciferase mutant (B).  
Fig. 2. Thermal inactivation of x12 Fluc and subset mutants. 
3.2 Effect of pH on x12 Fluc activity 
Detailed investigation on the pH-dependence of luciferase mutant activity revealed a 
significant further improvement in pH-tolerant profile from that of 5 Fluc (Law et al., 2006). 
The normalised pH-dependence of activity was shown to facilitate comparison of activity 
across the range of pH values (Fig. 3A). The non-normalised results for 12 Fluc and UG 
emphasize the increase in activity for the 12 Fluc relative to UG (Fig. 3B). The high level of 
activity ( 80 % of maximum activity) exhibited by 12 Fluc across a range of physiologically 
relevant pH values (6.6 – 8.6) is likely to offer greater sensitivity and reliability when used in 
place of existing luciferase mutants in many applications, particularly those requiring a 
lower pH than the optimal for for Fluc or those that experience pH fluctuations such as 
whole cell or animal imaging (Frullano et al., 2010). 
3.3 Bioluminescence spectra and kinetic properties of WT Fluc, x12 Fluc and UG with 
LH2 and ALH2 
The bioluminescence spectrum of WT Fluc is known to undergo a classic red 
bathochromic shift with LH2 at low pH, whereas x12 Fluc and UG maintained consistent 
yellow-green colours emission maximum of 557 nm and 560 nm respectively over the 
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investigated pH range of 6.2-8.8, (Table 2). Neither x12 nor UG showed any significant 
widening of the spectra at lower pH. Overall, bioluminescence spectra of x12 were even 
less pH-dependant than those of UG. Both thermostable mutants would be expected to 
retain their colour under physiological conditions, which may be pertinent to 
multispectral imaging. The tolerance of x12 Fluc to low pH may give it further advantage 
in terms of signal strength.  
 
A B 
Luciferase activity (20 l at 0.42 M) was assayed by the manual mixing with 180 l of TEM, 1.11 mM 
ATP, 222 M LH2, 300 M CoA over a range of pH values between 6.0 and 9.5. Bioluminescence was 
integrated over 5 s using the luminometer at a PMT voltage of 550 mV: normalised to each luciferase 
enzyme total activity data (A) and non-normalised data (B). Measurements for UG were carried out 
using a PMT voltage of 700 mV to obtain good signal-to-noise ratio readings; data presented for the 
non-normalised curve have been corrected for the different PMT voltage used. The lag-time between 
initiation of the reaction and recording of light emission was ~ 5s. Measurements at each pH were 
carried out in triplicate. Error bars represent one S.E.M. within triplicate measurements.  
Fig. 3. Effect of pH on the activity of WT, UG, x5 and x12 Fluc. 
Kinetic parameters including Michaelis-Menten constants (Km) and catalytic constant (Kcat) 
were measured for the WT, x12 and UG luciferases with LH2 and ALH2. The Kms of x12 
Fluc (6.8 M) and UG (3.7 M) for LH2 were lower than that of WT Fluc (18M) (Table 3), 
indicating an increase in affinity of the thermostable enzymes for LH2 relative to the WT. 
Even stabilising mutations far from the active site can affect tertiary structure and lead to 
increased substrate affinities and altered enzyme kinetics (Squirrell et al., 1999). Catalytic 
efficiency characterised by Kcat/Km ratio was significantly compromised in both 
thermostable luciferases as compared to the WT, with UG being more thermostable but less 
catalytically efficient than x12. In terms of specific activity x12 Fluc retained only 15% of the 
specific activity of the WT, exceeding that of UG by four-fold. 
For in vivo applications involving imaging of protease activity where ALH2 is to be detected 
instead of LH2. Therefore, bioluminescence properties of these mutants with ALH2 were 
tested. WT Fluc is known to produce pH independent orange-red emission with ALH2 
(White et al., 1966) and here it was seen that WT Fluc, x12 Fluc and UG were red-shifted to 
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the emission maximum of 601 nm, 592 nm and 585 nm, respectively (Table 4). UG and x12 
Fluc also had narrower half-bandwidth with ALH2 than WT Fluc, which may indicate that 
more rigid active sites of UG and x12 Fluc confer better protection to the emitter than WT 
Fluc with ALH2.  
 
Mutants 
Bioluminescent spectra
λmax (nm) Half-bandwidth (nm) 
pH pH
6.5 7.8 8.8 6.5 7.8 8.8 
WT 592 559 558 91 66 66 
x12 565 557 558 66 66 67 
UG 562 560 559 73 68 70 
x2 594 568 568 86 84 85 
x4 560 558 561 69 66 70 
x5 559 559 558 68 63 62 
0.31 nmol of each mutant was added to 150 µM LH2 and 1 mM ATP in chilled 0.1 M TEM buffer, 
adjusted to a varying pH and spectra were measured after 30 s at ca. 25ºC. Half-bandwidths are widths 
of spectra at half maximum intensity. Data were corrected for PMT spectral response. UG was assayed 
at pH 6.2 not 6.5. Standard error +2nm.  
Table 2. Bioluminescent spectra of the WT, Fluc mutants and UG with LH2 at different pH 
Mutants 
Michaelis-Menten kinetic parameters Specific activity 
Km, µM 
Kcat x 108, 
RLU/s 
Kcat/ Km x 1013, 
RLU/ s x µM 
x 107, 
RLU/mg 
% of WT at 
pH 7.8 
WT 18+1 1129+215 668+157 24.25+0.14 100 
x12 6.8+0.2 50+3 74+2 3.56+0.04 15 
UG 3.7+0.08 19+2 53+8 0.98+0.02 4 
x2 12+2 1260+181 1149+110 11.37+0.03 47 
x4 28+3 574+84 201+7 16.59+1.53 68 
x5 9.5+1.5 1202+142 1288+51 21.33+0.04 88 
Kinetic parameters were derived from flash heights (Hanes, 1932) by varying LH2 concentration in the 
range of 0.2 -500 M in the presence of saturating 1 mM ATP (see Materials and Methods). Specific 
activity was determined in the presence of 20.1 pmol enzyme by integrating light in 20 ms pulses over 
12 s. PMT voltage 550 mV. 
Table 3. Kinetic parameters of WT, Fluc mutants and UG with LH2 
In terms of kinetic parameters significant differences were observed in Km and Kcat values 
for LH2 and ALH2 between the WT and thermostable luciferases. In the WT both Km and 
Kcat for ALH2 were significantly lower than for LH2, suggesting that WT Fluc has higher 
affinity for ALH2 than for LH2 (Shinde et al., 2006). In thermostable x12 Fluc both Km and 
Kcat for ALH2 were very close to those of LH2, while in UG Km for ALH2 was higher and 
Kcat was lower than for LH2. The mutations that invoke thermostability increase the affinity 
of Fluc for LH2, but reduce it for ALH2. WT Fluc had nearly 10-fold higher catalytic 
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efficiency (Kcat/Km) with LH2 and ALH2 than x12 Fluc. x12 demonstrated comparable 
Kcat/Km ratio for both substrates, favouring its use with ALH2 while UG had a similar 
catalytic efficiency to x12 Fluc for LH2, but 23-times lower Kcat/Km for ALH2 . Overall, x12 
Fluc seems to be a mutant of choice to be used with ALH2. 
 
Mutants 
Bioluminescent spectra
λmax (nm) Half-bandwidth (nm) 
pH pH
6.5 7.8 8.8 6.5 7.8 8.8 
WT 599 601 601 74 79 79 
x12 596 592 591 72 72 71 
UG 588 585 584 71 72 71 
x2 596 596 595 76 76 74 
x4 596 597 593 74 74 74 
x5 599 600 599 74 76 73 
0.31 nmol of each mutant was added to 100 µM ALH2 and 3 mM ATP in chilled 0.1 M TEM buffer, 
adjusted to a varying pH and spectra were measured after 30 s at ca. 25ºC. Half bandwidths are widths 
of spectra at half maximum intensity. Data were corrected for PMT spectral response. UG was assayed 
at pH 6.2 not 6.5. Standard error +2nm. 
Table 4. Bioluminescent spectra of the WT, Fluc mutants and UG with ALH2 at different pH 
WT Fluc appears to provide stringent interactions dictating reaction kinetics with ALH2, but 
not those that govern the emitting species. This may also be indicated by larger half-
bandwidths of bioluminescence spectra with ALH2 than with LH2. Low Km values were 
proposed to correlate with more blue-shifted emission (Kutuzova et al., 1997), but this is not 
always true and it is possible for Km to be more linked to bioluminescence spectra half-
bandwidth, i.e. the extent of vibrational freedom of oxyluciferin (Viviani et al., 2001). 
However, here, WT Fluc has wider spectral half-bandwidth with ALH2 as compared to LH2, 
but lower Km. WT Fluc had only 10% of the specific activity with ALH2 as compared to LH2 
at pH 7.8 (Table 5). On the contrary, x12 Fluc’s activity with ALH2 (6%) is only 2.5-fold 
lower than that with LH2 (15%), while UG had as low as 4% with both substrates. Reasons 
for lower Vm and red-shifted emission of WT Fluc with ALH2 have been postulated (Shinde 
et al., 2006; McCapra  and Perring, 1985; Wada et al., 2007).  
3.4 Properties of thermostable mutants containing subsets of x12 Fluc mutations 
Elimination of bathochromic shift at low pH, increase in thermostability and pH-tolerance 
were associated with the significant reduction in specific activity and changes in the 
essential kinetic parameters. In an attempt to identify mutations responsible for the 
undesirable associated changes and to improve the understanding of kinetics and activity 
differences between WT Fluc and x12 Fluc with LH2 and ALH2 a number of thermostable 
enzymes with subsets of x12 Fluc mutations were investigated (Table 1). These were x2 Fluc 
(E354R/ D357Y) (Baggett et al., 2004), x4 Fluc (T214A/ I232A/ F295L/ E354K) (Tisi et al., 
2002) and x5 Fluc (F14R/ L35Q/ V182K/ I232K/ F465R) (Law et al., 2006). Among the 
subset mutants only x2 showed bathochromic shift with LH2 at low pH, similar to that 
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observed in the WT (Table 2). x4 and x5 Flucs resisted red-shift at low pH in line with x12. 
With ALH2 none of the subset mutants showed any significant shift in the bioluminescence 
across the investigated pH range, which was similar to the behaviour of x12, WT and UG 
with this substrate (Table 4).  
 
Mutants 
Michaelis-Menten kinetic parameters Specific activity 
Km, µM 
Kcat x 108, 
RLU/s 
Kcat/ Km x 1013, 
RLU/ s x µM 
x 107, 
RLU/mg 
% of WT 
with LH2 at 
pH 7.8 
WT 2.4+0.4 174+13 849+158 2.06+0.01 8 
x12 6.5+0.2 38+4 59+9 1.46+0.01 6 
UG 8.1+2.19 1.4+0.04 2.3+0.7 0.60+0.01 4 
x2 2.3+0.1 226+24 956+68 1.99+0.03 8 
x4 9+1 144+14 166+14 2.51+0.03 10 
x5 1.6+0.1 215+32 1343+184 2.07+0.01 9 
Kinetic parameters were derived from flash heights (Hanes, 1932) by varying ALH2 concentration in the 
range of 0.1-600 M used with 3mM ATP to saturate (see Materials and Methods). Specific activity was 
determined in the presence of 20.1 pmol enzyme by integrating light in 20 ms pulses over 12 s. PMT 
voltage 550 mV. 
Table 5. Kinetic parameters of WT, Fluc mutants and UG with ALH2 
In terms of kinetic parameters, if compared to the WT, the effect of mutations in x4 on Km 
and Kcat with LH2 differed significantly from mutations in both x2 and x5 subsets (Table 3). 
Mutations in x4 increased the Km, while in two other subsets decreased it, and reduced the 
Kcat, while in the other subsets hardly any change was observed. These results correlated 
well with the previously reported in literature (Law et al., 2006; Tisi et al., 2002; Prebble et al., 
2001; Branchini et al., 2007). Similar trends were observed in the kinetic parameters for ALH2 
(Table 5). Mutations in x4 significantly increased its Km for this substrate (as in x12), while 
two other mutants slightly decreased it. Kinetics of the x4 mutant with ALH2 exhibited 
slower rise and slower decay, reminiscent of the kinetics of x12, whereas x2 and x5 
displayed a sharp flash that strongly resembled the WT.  
The differences in kinetic parameters and flash kinetics suggested that an undesirable effect 
of mutations was common to x4 and x12 mutants, but not to x2 or x5, on catalysis with both 
LH2 and ALH2. It was hypothesised that reversion of buried x12 Fluc mutations T214C and 
F295L might enhance its catalytic properties.  
3.5 Properties of T214 and F295 revertant mutants of x12 Fluc 
x12 Fluc mutations T214C and F295L were individually reverted and their bioluminescent 
properties, catalytic parameters and thermal stability investigated. Bioluminescence spectra 
of both revertants were measured and found to match those of x12 Fluc with both substrates 
(Table 6). F295 revertant showed no bathochromic shift with either substrate and retain the 
pH-tolerance previously observed in x12 Fluc. T214 revertant had a flash kinetics similar to 
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x12 Fluc with both substrates, but F295 had a faster and brighter flash with LH2, more 
resembling that of the WT (not shown). 
Mutants Substrate 
Bioluminescent spectra
λmax (nm) Half-bandwidth (nm) 
pH pH
6.5 7.8 8.8 6.5 7.8 8.8 
x12 
LH2 565 557 558 66 66 67 
ALH2 596 592 591 72 72 71 
T214 
LH2 - 560 - - 66 - 
ALH2 - 591 - - 72 - 
F295 
LH2 563 559 560 71 66 70 
ALH2 593 592 591 70 72 73 
Details are as in Table 2 and 4. 
Table 6. Bioluminescent spectra of x12 Fluc and its revertants at different pH with LH2 and 
ALH2  
T214 revertant exhibited Kms and Kcats similar to x12 Fluc for LH2 and its Kcat/Km ratio 
was not significantly different from that of x12 Fluc (Table 7). The Km of T214 for ALH2 was 
slightly lower than x12 Fluc and Kcat elevated, resulting in the higher Kcat/Km ratio. T214 
revertant had similar specific activities to x12 Fluc with both substrates. However, the Km of 
F295 revertant for both LH2 and ALH2 was lower and Kcat was higher than that of x12 Fluc 
resulting in a much higher Kcat/Km ratio. Specific activity of F295 revertant with both 
substrates was two-fold brighter than that of x12 Fluc. As a result of these findings F295 
revertant afforded higher sensitivity to the flash-based detection of LH2 and ALH2 than x12 
Fluc. It is possible to conclude that in x12 Fluc residue F295 contributes much more to 
catalysis than T214 and its reverse-mutation may significantly improve the performance of 
x12 Fluc providing it has no negative effect on the thermostability. 
 
Mutants Substrate
Michaelis-Menten kinetic Specific activity 
Km, µM
Kcat x 108, 
RLU/s 
Kcat/ Km x 1013, 
RLU/ s x µM 
x 107, 
RLU/mg 
% of x12 with 
LH2 at pH 7.8 
x12 
LH2 6.8+0.2 50+3 74+2 3.56+0.04 100 
ALH2 6.5+0.2 38+4 59+9 1.46+0.01 40 
T214 
LH2 6.2+0.5 49+3 83+10 3.22+0.03 79 
ALH2 4.9+0.5 66+2 138+8 2.37+0.05 58 
F295 
LH2 3.7+0.2 133+6 366+22 8.03+0.09 197 
ALH2 3.6+0.2 82+2 231+9 3.23+0.02 79 
Details are as in Table 3 and 5. Specific activity was measured at pH 7.7 with LH2 and at pH 8.2 with ALH2. 
Table 7. Kinetic parameters of x12 Fluc revertants with LH2 and ALH2   
Although T214C and F295L are thermostabilising mutations (Law et al., 2006; Tisi et al., 
2002), revertants displayed resistance to thermal inactivation similar to that of x12 Fluc at 
40ºC and 50ºC (Fig. 4). Therefore, the mutation F295L is not essential for practically useful 
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thermostability properties of x12 Fluc, but in the framework of this enzyme contributes to 
reduced activity and catalytic efficiency with both LH2 and ALH2. F295 revertant was 
hereafter named x11 Fluc. Cumulative addition of multiple phenotype-inducing mutations 
may enhance desired mutant properties, but some additions can clash and unduly disrupt 
properties.  
 
Flash-based activity with LH2 was compared in aliquots of 0.5 M enzyme incubated at set 
temperatures over time. Samples were equilibrated to RT before dispensing 260 l of 70 M LH2 and 1 
mM ATP solution in TEM buffer (pH 7.8) onto 40 µl luciferase mutants. Solid lines: 40ºC, dashed lines: 
50ºC. 
Fig. 4. Thermal inactivation of x12 Fluc and revertants at 40ºC and 50ºC. 
3.6 In vivo imaging 
Human retrovirus encoding Ppy Fluc or x11 Fluc genes bearing a myc tag was used to 
transduce Raji cells, which were sorted to the same expression levels (Fig. 5A) by flow 
cytometric sorting for myc tag staining and cultured at 37ºC. As an example of in vivo 
imaging using x11 Fluc, one million Raji cells expressing similar levels of WT or x11 Flucs 
were injected into the tail veins of immunocompromised Beta2m-mice to induce systemic 
lymphoma (Chao et al., 2011) and imaged after i.p. administration of LH2. Images revealed 
light signals predominantly from brain, spine and hips. x11 Fluc appeared very bright in 
vivo (Fig. 5B) because of its high thermostability and pH tolerance along with favourable 
kinetic parameters demonstrated in characterisation. It is expected to perform equally well 
under the changing physiological pH conditions and in combination with aminoluciferin 
used for imaging of protease assays in vivo. Further work to codon-optimise and test this 
mutant in mammalian cells is underway and will be published shortly. 
4. Conclusion 
In the present study, we describe the construction and characterisation of the firefly 
luciferase mutant 12 Fluc based on the mutations previously identified as increasing 
thermostability of the enzyme. Detailed characterization of its bioluminescent and 
biochemical properties revealed that it is the only luciferase mutant reported to exhibit 
 80 % of total activity across a wide pH range of 6.6 - 8.8 covering physiologically 
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significant pH at the lower end. Additionally, it possesses sufficient thermal stability to be 
applicable to assays that require temperatures lower than 50C or in assays involving short 
lengths of higher temperature exposure. This mutant could be beneficial for in vivo imaging 
with luciferin, particularly in assays that experience pH fluctuations, and for 
bioluminescence protease assays or in vivo protease imaging, in which the sensitivity of 
detection may be dependent on the sensitivity of ALH2 detection. The latter assays could 
benefit further from increased brightness. 
A. 
B. 
FACS histogram showing expression of WT Fluc and thermostable mutants in Raji cells. Cells obtained 
by fluorescence activated cell sorting were expanded in vitro and expression of transgenes was analysed 
using a Cyan flow cytometer using anti-myc.FITC staining. Non-transduced cells (blue line – filled) 
were compared to WT Fluc (red line) and x11 Fluc (blue line – dashed) (A). In vivo imaging of systemic 
lymphoma expressing WT Fluc (left) and x11 mutant (right). Mice with lymphomas expressing either 
WT Fluc or x11 Fluc were imaged in three groups of three mice (B).     
Fig. 5. Expression and example of in vivo imaging of Flucs in mammalian cells. 
The brightness of x12 Fluc was improved by identifying the mutation at the 295 position as 
having the major negative impact on the bioluminescent characteristics, reverting it and 
creating x11 Fluc, which possessed all the desirable properties. x11 Fluc has remarkably high 
activity and catalytic efficiency with LH2 and ALH2, coupled to a high resistance to thermal 
inactivation and pH-tolerance. Its highly advantageous properties in terms of stability and 
brightness in mammalian cells have been demonstrated using systemic lymphoma 
expressing the mutant in mice as an example, as there was no normalisation for engraftment 
and no statistical difference between WT and x11 in this small sample set.  
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